Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

FDA approves Ohmeda's neuromuscular blocking agent

March 19, 1997

BioChem Pharma synthesizes opioid analgesics/NMDA antagonists

March 19, 1997

Cephalon discloses cysteine/serine protease inhibitors

March 19, 1997

Avonex approved by European Commission

March 18, 1997

Lanepitant not effective in migraine

March 18, 1997

Pharmacodynamics and safety of the dopamine agonist CI-1007

March 18, 1997

Topical anesthesia with liposome-encapsulated tetracaine

March 18, 1997

Neuroprotective, analgesic and antitussive agents from Toray

March 18, 1997

Aricept cleared for marketing in U.K.

March 17, 1997

New therapy for essential tremor recommended for approval

March 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...